Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Fluorocholine PET/MRI and PET/CT for Parathyroid Tumors
NCT07444723Phase 3Recruiting
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Apr 2026
- Primary completion
- Feb 2035
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 18F-choline in primary hyperparathyroidism (PHPT), parathyroid cancer, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Apr 2026; status: recruiting.
02
Drugs
18F-choline
03
Conditions
primary hyperparathyroidism (PHPT)parathyroid cancer
Beyond the preview
Go deeper on NCT07444723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07444723.